INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL. (12th June 2019)

• Record Type: Journal Article
• Authors: Jaeger, U.; Tam, C.; Borchmann, P.; McGuirk, J.; Holte, H.; Waller, E.; Jaglowski, S.; Andreadis, C.; Foley, S.R.; Fleury, I.; Westin, J.; Teshima, T.; Mielke, S.; Salles, G.; Ho, P.J.; Izutsu, K.; Schuster, S.; Bachanova, V.; Maziarz, R.; Van Besien, K.; Kersten, M.J.; Wagner‐Johnston, N.; Kato, K.; Corradini, P.; Tiwari, R.; Forcina, A.; Pacaud, L.; Bishop, M.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 505
• Page End: 507
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.189_2631
• Languages: English
• ISSNs: 0278-0232